ASCP 2026-2029 Strategic Plan
Four Pillars:
Influence & Innovation
Connection & Growth
Collaboration & Quality
Visibility & Value
Mission:
Position ASCP as the leading source for innovative, independent, and evidence-based education in clinical psychopharmacology, while building a thriving professional community and elevating clinical trial quality.
Vision:
A future where ASCP's collaborative leadership across academia, industry, and government transforms clinical psychopharmacology research, education and patient care worldwide.
Influence & Innovation
Position ASCP as the leading source for innovative, independent, and evidence-based education in clinical psychopharmacology.
| Enhance Annual Meeting Experience |
Develop Year-Round Educational Programming |
Expand Comprehensive Psychopharmacology Curriculum |
Connection & Growth
Build a thriving community that attracts and sustains the next generation of clinical psychopharmacology professionals.
|
Establish Residency & Training Program Partnerships |
Strengthen Early Career Member Support |
Improve Early Career Member Retention |
Collaboration & Quality
Leverage ASCP's unique collaborative relationships to elevate clinical trial quality and advance the field.
|
Strengthen Industry & CRO Relationships for Research Quality |
Strengthen Government Engagement & Policy Advocacy |
Launch Collaborative Research Initiatives |
Visibility & Value
Amplify ASCP's visibility and authority as a thought leader to drive membership growth and demonstrate clear value.
|
Execute Marketing & Visibility Campaign |
Articulate & Deliver Member Value Beyond Meeting |
Enhance Policy Education & Civic Engagement |